<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
     xmlns:georss="http://www.georss.org/georss"
     xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#"
     xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
        <title><![CDATA[Stocks dip after gains from vaccine-fueled rally on Wall Street]]></title>
        <atom:link href="https://usagag.com/2020/05/19/stocks-dip-after-gains-from-vaccine-fueled-rally-on-wall-street/" rel="self" type="application/rss+xml" />
        <link>https://usagag.com/2020/05/19/stocks-dip-after-gains-from-vaccine-fueled-rally-on-wall-street/</link>
        <lastBuildDate>Tue, 19 May 2020 14:19:02 +0000</lastBuildDate>
        <sy:updatePeriod>hourly</sy:updatePeriod>
        <sy:updateFrequency>1</sy:updateFrequency>
        <generator>https://usagag.com</generator>
        <media:content url="/uploads/2020/05/stocks-dip-after-gains-from-vaccine-fueled-rally-on-wall-street.jpg" medium="image">
            <media:title type="html">Stocks dip after gains from vaccine-fueled rally on Wall Street</media:title>
        </media:content>
        <content:encoded><![CDATA[<p>US stocks slid Tuesday as investors reined in their optimism about a <strong>promising coronavirus vaccine</strong>.</p><p>The Dow Jones industrial average dipped as much as 135.71 points, or 0.5 percent, to 24,461.66 in early trading to give back some its 900-point Monday rally. Hardware store chain Home Depot led the blue-chip index lower with its shares dropping 2.9 percent on disappointing earnings.</p><p>The S&amp;P 500 also fell as much as 0.4 percent at the open after posting its best day in six weeks on Monday, while the tech-heavy Nasdaq eked out an early 0.2 percent gain Tuesday.</p><p>The muted movements marked a pullback from Wall Street&#8217;s enthusiasm about progress toward a COVID-19 vaccine from biotech firm Moderna. While a vaccine is key to reopening the global economy after a pandemic-induced shutdown, experts said investors&#8217; excitement was exaggerated given the small scale of Moderna&#8217;s early trial, which had only 45 participants.</p><p>&#8220;Given the exceedingly long runway for a vaccine to be made available en masse and the short-term nature of news trading, it makes sense for some traders to fade the move based on previous disappointments,&#8221; said Stephen Innes, chief global market strategist at AxiCorp.</p><p>The early drop came ahead of Federal Reserve chairman Jerome Powell&#8217;s Tuesday morning testimony before the US Senate Banking Committee. Powell, who will appear with Treasury Secretary Steven Mnuchin, has recently thrown cold water on investors&#8217; hopes for a quick recovery from the economic downturn the virus crisis has caused.</p><p><em>With Post Wires</em></p>]]></content:encoded>
                <dc:creator><![CDATA[USAGAG]]></dc:creator>
            </channel>
</rss><!--Time: 0.070379018783569-->